Servicio de Medicina Intensiva, Hospital Universitario Dr. Peset Valencia Avda Gaspar Aguilar, 90, 46017. Valencia, Spain.
Rev Esp Quimioter. 2013 Jun;26(2):131-50.
Although there has been an improved management of Invasive Candidiasis in the last decade, controversial issues still remain, especially in the diagnostic and therapeutic approaches.
We sought to identify the core clinical knowledge and to achieve high level agreement recommendations required to care for critically ill adult patients with Invasive Candidiasis.
Prospective Spanish survey reaching consensus by the Delphi technique, anonymously conducted by electronic e-mail in a first term to 25 national multidisciplinary experts in invasive fungal infections from five national scientific societies, including Intensivists, Anesthesiologists, Microbiologists, Pharmacologists and Infectious Disease Specialists, responding to 47 questions prepared by a coordination group after a strict review of the literature in the last five years. The educational objectives spanned five categories, including epidemiology, diagnostic tools, prediction rules, and treatment and de-escalation approaches. The level of agreement achieved among the panel experts in each item should exceed 75% to be selected. In a second term, after extracting recommendations from the selected items, a face to face meeting was performed where more than 80 specialists in a second round were invited to validate the preselected recommendations.
In the first term, 20 recommendations were preselected (Epidemiology 4, Scores 3, Diagnostic tools 4, TREATMENT 6 and De-escalation approaches 3). After the second round, the following 12 were validated:
Think about Candidiasis in your ICU and do not forget that non-albicans species also exist. DIAGNOSTIC TOOLS: Blood cultures should be performed under suspicion every 2-3 days and, if positive, every 3 days until obtaining the first negative result. Obtain sterile fluid and tissue, if possible (direct examination of the sample is important). Use nonculture based methods of microbiological tools, whenever possible. Determination of antifungal susceptibility is mandatory. SCORES: As screening tool, use the Candida Score and determine multicolonization in high risk patients.
Start early. Choose Echinocandins. Withdraw the catheter. Fundoscopy is needed. DE-ESCALATION: Only applied when knowing susceptibility determinations and after 3 days of clinical stability. The higher rate of agreement was achieved in the optimization of microbiological tools and the withdrawal of the catheter, whereas the lower rate corresponded to de-escalation therapy and the use of scores.
The management of invasive candidiasis in ICU patients requires the application of a broad range of knowledge and skills that our summarized in our recommendations. These recommendations may help to identify the potential patients, standardize their global management and improve their outcomes, based on the DELPHI methodology.
尽管在过去十年中侵袭性念珠菌病的管理有所改善,但仍存在一些有争议的问题,尤其是在诊断和治疗方法方面。
我们试图确定核心临床知识,并就治疗重症成年侵袭性念珠菌病患者所需的高水平共识性建议达成一致。
通过德尔菲技术进行前瞻性西班牙调查以达成共识,第一阶段通过电子邮件匿名向来自五个国家科学协会的25名全国多学科侵袭性真菌感染专家进行调查,这些专家包括重症监护医生、麻醉师、微生物学家、药理学家和传染病专家,他们回答了协调小组在对过去五年的文献进行严格审查后准备的47个问题。教育目标涵盖五个类别,包括流行病学、诊断工具、预测规则以及治疗和降阶梯治疗方法。专家小组在每个项目上达成的一致水平应超过75%才能被选中。在第二阶段,从选定的项目中提取建议后,举行了一次面对面会议,邀请了80多名专家在第二轮会议中对预先选定的建议进行验证。
在第一阶段,预先选定了20条建议(流行病学4条、评分3条、诊断工具4条、治疗6条和降阶梯治疗方法3条)。第二轮之后,以下12条建议得到了验证:
在您的重症监护病房中考虑念珠菌病,不要忘记非白色念珠菌菌种也存在。
如有怀疑,应每2 - 3天进行一次血培养,若培养结果为阳性,则每3天进行一次,直至首次获得阴性结果。尽可能获取无菌体液和组织(对样本进行直接检查很重要)。尽可能使用基于非培养的微生物学工具。必须确定抗真菌药敏性。
作为筛查工具,使用念珠菌评分并确定高危患者的多重定植情况。
尽早开始。选择棘白菌素类药物。拔除导管。需要进行眼底检查。
仅在了解药敏结果且临床稳定3天后应用。在优化微生物学工具和拔除导管方面达成的一致率较高,而在降阶梯治疗和评分的使用方面达成的一致率较低。
重症监护病房患者侵袭性念珠菌病的管理需要应用广泛的知识和技能,我们的建议对此进行了总结。基于德尔菲方法,这些建议可能有助于识别潜在患者、规范其整体管理并改善其治疗结果。